Podiatrists in Pasco, WA Accepting Medicare

5 Podiatrists found. Showing 1 - 5

Dr. Brent James Thielges, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 9613 Sandifur Pkwy Ste B, Pasco, WA 99301 Phone: 509-591-9454    Fax: 509-578-1118

Tri-city Foot & Ankle Center, Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 9613 Sandifur Pkwy Ste B, Pasco, WA 99301 Phone: 509-591-9454    Fax: 509-578-1118

Dr. Joshua Benjamin Grimm, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 9613 Sandifur Pkwy Ste B, Pasco, WA 99301 Phone: 509-591-9454    Fax: 509-578-1118

Dr. Theresa M Ledbetter, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 704 W Margaret St, Pasco, WA 99301 Phone: 509-545-5906    Fax: 509-547-5999

Theresa Ledbetter Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 704 W Margaret St, Pasco, WA 99301 Phone: 509-545-5906    Fax: 509-547-5999

News Archive

U.S. must maintain leadership in AIDS fight, bipartisan support of PEPFAR

Through travel to Africa and "as chairman and ranking member of the Senate Foreign Relations Subcommittee on African Affairs, we've seen firsthand the enormous toll of HIV/AIDS on families, communities and economies," Sen. Chris Coons (D-Del.) and Sen. Johnny Isakson (R-Ga.) write in the Huffington Post's "Politics" blog.

Biventricular pacing best in atrioventricular block patients

Use of biventricular rather than conventional right ventricular pacing results in better clinical outcomes in patients who have heart failure with atrioventricular block and left ventricular systolic dysfunction, show the results of BLOCK HF.

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research with an aggressive set of technology initiatives. The goal is to take advantage of an explosion in new medical data to drive tighter linkage between research and the practice of medicine to achieve breakthroughs.

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

Read more Medical News

› Verified 5 days ago